financetom
Business
financetom
/
Business
/
aTyr Pharma's lung disease drug misses main goal in late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
aTyr Pharma's lung disease drug misses main goal in late-stage trial
Sep 15, 2025 5:12 AM

Sept 15 (Reuters) - aTyr Pharma ( ATYR ) said on Monday

its experimental drug did not meet the main goal in a late-stage

study in patients with a type of lung disease known as pulmonary

sarcoidosis.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved